MaxCyte, Inc. Highlights Innovations in Scalable, High-Throughput Transient Transfection for Streamlining Antibody Development and Production at PepTalk 2013, Booth #307
1/22/2013 9:46:40 AM
GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting a series of events at Cambridge Healthtech Institute’s 12th Annual PepTalk to be held January 21-25 in Palm Springs, CA. MaxCyte will present antibody development case studies in a scientific talk, detail breakthrough data in a technical poster, and schedule one-on-one discussions in Booth #307 to demonstrate how the MaxCyte STX® Scalable Transfection System and MaxCyte VLX® Large Scale Transfection System can improve the speed, biologic relevance, and process design for protein and antibody screening and manufacturing.